drugset / Trial / NCT06750627

Efficacy of Continuous Erector Spinae Plane Block to Reduce Postoperative Pain in Patients Undergoing Unilateral Thoracotomy

NCT06750627

Phase 4 Not yet recruiting 30 enrolled Udayana University
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to learn if continuous Erector Spinae Plane Block (ESPB) reduces postoperative pain in patients undergoing unilateral thoracotomy. It will also evaluate the safety and effectiveness of continuous ESPB. The total participants needed will be 30 persons. The main questions it aims to answer are: * Does continuous ESPB lower the intensity of postoperative pain compared to multimodal intravenous analgesia? * Does continuous ESPB increase the time to first analgesic request? * Does continuous ESPB reduce the amount of intravenous opioids required in the first 48 hours after surgery? * Does continuous ESPB improve the overall recovery quality within 48 hours post-surgery? Participants will: * Receive continuous ESPB or multimodal intravenous analgesia after the surgery. * Undergo routine pain assessments, and recovery evaluations using tools like the Visual Analogue Scale (VAS) and Quality of Recovery-15 (QoR-15). * Participate in follow-up visits for data collection on pain, opioid usage, and recovery quality.

Timeline

Start
2025-01-01
Primary completion
2025-03-31
Completion
2025-05-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 1000 mg Intravenous
Background Bupivacaine Other / unclassified 0.25 % Other
Background Bupivacaine Other / unclassified 25 ml Other
Comparator Ketorolac Other / unclassified 30 mg Intravenous
Comparator Morphine Other / unclassified 30 mg Intravenous

Indications

No indication recorded.